Mirae Asset Global Investments’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43K | Buy |
193
+28
| +17% | +$207 | ﹤0.01% | 1572 |
|
|
2025
Q1 | $1.57K | Hold |
165
| – | – | ﹤0.01% | 1543 |
|
|
2024
Q4 | $6.18K | Buy |
+165
| New | +$6.18K | ﹤0.01% | 1543 |
|
|
2024
Q2 | – | Sell |
-2,165
| Closed | -$226K | – | 2145 |
|
|
2024
Q1 | $226K | Buy |
+2,165
| New | +$226K | ﹤0.01% | 2214 |
|
|
2023
Q3 | – | Sell |
-2,284
| Closed | -$187K | – | 2620 |
|
|
2023
Q2 | $187K | Sell |
2,284
-279
| -11% | -$22.8K | ﹤0.01% | 2367 |
|
|
2023
Q1 | $263K | Buy |
2,563
+742
| +41% | +$76.2K | ﹤0.01% | 2226 |
|
|
2022
Q4 | $267K | Buy |
1,821
+470
| +35% | +$68.8K | ﹤0.01% | 2200 |
|
|
2022
Q3 | $228K | Buy |
1,351
+446
| +49% | +$75.3K | ﹤0.01% | 2285 |
|
|
2022
Q2 | $104K | Buy |
+905
| New | +$104K | ﹤0.01% | 2301 |
|